Skip to main contentU.S. National Library of MedicineU.S. National Library of Medicine


Profiles in Science
   
Pinterest badge Follow Profiles in Science on Pinterest!

The Edward D. Freis Papers

Title:
A Clinical Appraisal of Pentapyrrolidinium (M&B 2050) in Hypertensive Patients pdf (954,891 Bytes) ocr (29,728 Bytes)
A Clinical Appraisal of Pentapyrrolidinium (M&B 2050) in Hypertensive Patients
Description:
Here, Freis's team studied the effectiveness of pentapyrrolidinium (a ganglionic-blocking agent, also called pentolinium) as an antihypertensive treatment. They concluded that the drug had several advantages in the treatment of severe hypertension over another ganglionic-blocking agent, hexamethonium. The drug's attributes, longer duration of action, greater potency, and a more uniform response to oral administration, more than compensated for its side effects and the frequent need to adjust dosage.
Number of Image Pages:
7 (954,891 Bytes)
Date:
1954-04 (April 1954)
Creator:
Freis, Edward D.
Partenope, Edward A.
Lilienfield, Lawrence S.
Rose, John C.
Source:
Periodical: Freis, Edward D., Edward A. Partenope, Lawrence S. Lilienfield, and John C. Rose. "A Clinical Appraisal of Pentapyrrolidinium (M&B 2050) in Hypertensive Patients." Circulation IX, 4 (April 1954): 540-546. Article. 7 Images.
Publisher:
[American Heart Association]
Rights:
This item is in the public domain. It may be used without permission.
Subject:
Medical Subject Headings (MeSH):
Hypertension
Antihypertensive Agents
Hexamethonium
Pentolinium Tartrate
Exhibit Category:
The Veterans Administration Hospital and Georgetown University School of Medicine, 1949-1964
Box Number: 7
Folder Number: 11
Unique Identifier:
XFBBDB
Document Type:
Articles
Language:
English
Format:
application/pdf
image/tif
Physical Condition:
Good
Series: Writings and Lectures, 1942-2002
SubSeries: Articles and Essays, 1942-2001
Folder: Cl, 1942-77
Metadata Last Modified Date:
2007-04-18
Linked Data:
RDF/XML     JSON     JSON-LD     N3/Turtle     N-Triples